Biomain is doing well. Large investments has been made into technological know-how and patenting new innovations. ”We have worked hard during the last couple of years with consolidating and co-locating all parts of Biomain to Helsingborg and with the development of Biomain’s unique business concept. We are now able to move forward and strengthen the positive trend we have had in the Nordic markets and in focussed export markets in Europe”, says Biomain’s Chairman of the Board Anders Williamsson. As a natural step in our development we are now also strengthening our organisation through the appointment of Joakim Svensson as the new CEO of Biomain.
”Joakim Svensson has been working at Biomain for two years as Chief Operating Officer as the last assignment. He has the necessary competence and leadership skills required to build on the positive momentum at Biomain” Anders Williamsson comments. Biomain’s two main owners, Jerry Wiener and Joachim Samuelsson, will as before, work for the Biomain group in their capacity as board members.
For further information please contact Biomain’ Chairman of the Board Anders Williamsson at +46 708 72 18 65.
Biomain is an innovative dental company focussed on customized prosthetics. Biomain’s patented implant bridge I-Bridge2® with angulated screw channels is compatible with all leading implant systems. Biomain’s headquarter and modern production facility is located in Helsingborg, Sweden.